Tech Company Financing Transactions
Atreaon Funding Round
Private investors participated in a $8 million funding round for Atreaon. This venture round was announced on 10/26/2011.
Transaction Overview
Company Name
Announced On
10/26/2011
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1188 Centre St.
Newton Center, MA 02459
USA
Newton Center, MA 02459
USA
Phone
Website
Email Address
Not Recorded
Overview
The company has developed a synthetic version of the protein, called Atsttrin, and founded Atreaon to commercialize it as a treatment for arthritis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Chuanju Liu
Co-Founder
Jeffrey Su
Browse more venture capital transactions:
Prev: 10/26/2011: Sincerely venture capital transaction
Next: 10/26/2011: Prometheus Energy Group venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs